{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:25:00Z","timestamp":1776939900486,"version":"3.51.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"crossref","award":["ScHARR Project ID: 1533"],"award-info":[{"award-number":["ScHARR Project ID: 1533"]}],"id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s11136-025-03966-3","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T11:05:47Z","timestamp":1744887947000},"page":"2451-2470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An international compendium of health state utilities in people with HIV: a systematic review"],"prefix":"10.1007","volume":"34","author":[{"given":"Edith","family":"Poku","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Falzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Donatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"3966_CR1","doi-asserted-by":"publisher","unstructured":"Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293\u20139 https:\/\/doi.org\/\/https:\/\/doi.org\/10.1016\/s0140-6736(08)61113-7","DOI":"10.1016\/s0140-6736(08)61113-7"},{"key":"3966_CR2","unstructured":"British HIV Association (BHIVA). Standards of Care for People Living with HIV 2018. Available from: https:\/\/www.bhiva.org\/standards-of-care-2018."},{"key":"3966_CR3","unstructured":"National AIDS Trust. Providing coordinated care for people living with HIV [January 2020]. Available from: https:\/\/www.nat.org.uk\/sites\/default\/files\/Providing%20coordinated%20care%20briefing_0.pdf."},{"key":"3966_CR4","unstructured":"World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132023: WHO; 2022. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/360348\/9789240053779-eng.pdf?sequence=1."},{"issue":"1","key":"3966_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12916-016-0640-4","volume":"14","author":"JV Lazarus","year":"2016","unstructured":"Lazarus, J. V., Safreed-Harmon, K., Barton, S. E., Costagliola, D., Dedes, N., Del Amo, V. J., Gatell, J. M., Baptista-Leite, R., Mendao, L., Porter, K., Vella, S., & Rockstroh, J. K. (2016). Beyond viral suppression of HIV\u2014the new quality of life frontier. BMC Medicine, 14(1), 94. https:\/\/doi.org\/10.1186\/s12916-016-0640-4","journal-title":"BMC Medicine"},{"issue":"Suppl 1","key":"3966_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s40273-017-0550-0","volume":"35","author":"R Ara","year":"2017","unstructured":"Ara, R., Brazier, J., & Zouraq, I. A. (2017). The use of health state utility values in decision models. PharmacoEconomics, 35(Suppl 1), 77\u201388. https:\/\/doi.org\/10.1007\/s40273-017-0550-0","journal-title":"PharmacoEconomics"},{"key":"3966_CR7","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, GW. T. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 2015."},{"issue":"7","key":"3966_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40273-016-0389-9","volume":"34","author":"M Karimi","year":"2016","unstructured":"Karimi, M., & Brazier, J. (2016). Health, health-related quality of life, and quality of life: What is the difference? PharmacoEconomics, 34(7), 645\u2013649. https:\/\/doi.org\/10.1007\/s40273-016-0389-9","journal-title":"PharmacoEconomics"},{"issue":"3","key":"3966_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1023\/a:1015240103565","volume":"11","author":"AW Wu","year":"2002","unstructured":"Wu, A. W., Jacobson, K. L., Frick, K. D., Clark, R., Revicki, D. A., Freedberg, K. A., Scott-Lennox, J., & Feinberg, J. (2002). Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Quality of Life Research, 11(3), 273\u2013282. https:\/\/doi.org\/10.1023\/a:1015240103565","journal-title":"Quality of Life Research"},{"key":"3966_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/1477-7525-10-132","volume":"10","author":"BX Tran","year":"2012","unstructured":"Tran, B. X., Ohinmaa, A., & Nguyen, L. T. (2012). Quality of life profile and psychometric properties of the EQ-5D-5L in HIV\/AIDS patients. Health & Quality of Life Outcomes., 10, 132. https:\/\/doi.org\/10.1186\/1477-7525-10-132","journal-title":"Health & Quality of Life Outcomes."},{"key":"3966_CR11","unstructured":"National Institute for Health and Care Excellence (NICE). Position statement on use of the EQ-5D-5L value set for England 2019. Available from: https:\/\/www.nice.org.uk\/about\/what-we-do\/our-programmes\/nice-guidance\/technology-appraisal-guidance\/eq-5d-5l#:~:text=Since%202008%2C%20our%20preferred%20measure,adults%20has%20been%20EQ%E2%80%915D."},{"issue":"8","key":"3966_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2165\/00019053-200624080-00003","volume":"24","author":"DJ Clayson","year":"2006","unstructured":"Clayson, D. J., Wild, D. J., Quarterman, P., Duprat-Lomon, I., Kubin, M., & Coons, S. J. (2006). A comparative review of health-related quality-of-life measures for use in HIV\/AIDS clinical trials. PharmacoEconomics, 24(8), 751\u2013765. https:\/\/doi.org\/10.2165\/00019053-200624080-00003","journal-title":"PharmacoEconomics"},{"issue":"1","key":"3966_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12955-017-0778-6","volume":"15","author":"V Cooper","year":"2017","unstructured":"Cooper, V., Clatworthy, J., Harding, R., & Whetham, J. (2017). Measuring quality of life among people living with HIV: A systematic review of reviews. Health and Quality of Life Outcomes, 15(1), 220. https:\/\/doi.org\/10.1186\/s12955-017-0778-6","journal-title":"Health and Quality of Life Outcomes"},{"key":"3966_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12913-014-0640-z","volume":"15","author":"BX Tran","year":"2015","unstructured":"Tran, B. X., Nguyen, L. H., Ohinmaa, A., Maher, R. M., Nong, V. M., & Latkin, C. A. (2015). Longitudinal and cross sectional assessments of health utility in adults with HIV\/AIDS: A systematic review and meta-analysis. BMC Health Services Research, 15, 7. https:\/\/doi.org\/10.1186\/s12913-014-0640-z","journal-title":"BMC Health Services Research"},{"key":"3966_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hr\u00f3bjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., \u2026 Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"3","key":"3966_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jval.2019.01.004","volume":"22","author":"J Brazier","year":"2019","unstructured":"Brazier, J., Ara, R., Azzabi, I., Busschbach, J., Chevrou-S\u00e9verac, H., Crawford, B., Cruz, L., Karnon, J., Lloyd, A., Paisley, S., & Pickard, A. S. (2019). Identification, review, and use of health state utilities in cost-effectiveness models: An ISPOR good practices for outcomes research task force report. Value Health., 22(3), 267\u2013275. https:\/\/doi.org\/10.1016\/j.jval.2019.01.004","journal-title":"Value Health."},{"key":"3966_CR17","unstructured":"Centre for Reviews and Dissemination. CRD\u2019s guidance for undertaking reviews in health care: University of York; 2009."},{"key":"3966_CR18","unstructured":"Papaioannou D, Brazier J, Paisley S. NICE DSU Technical Support Document 9: The identification, review and synthesis of health state utility values from the literature 2010. Available from: http:\/\/nicedsu.org.uk\/wp-content\/uploads\/2016\/03\/TSD9-HSUV-values_FINAL.pdf."},{"key":"3966_CR19","unstructured":"National Institute for Health and Care Research (NIHR). Health state utility values in people living with human immunodeficiency virus (PLWH) - a systematic review: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=346286; 2022. Available from: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=346286."},{"key":"3966_CR20","unstructured":"National Institute for Health and Care Excellence (NICE). NICE health technology evaluations: the manual: process and methods 2022. Available from: https:\/\/www.nice.org.uk\/process\/pmg36\/chapter\/economic-evaluation."},{"issue":"1","key":"3966_CR21","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12955-020-01559-x","volume":"18","author":"JT Cooper","year":"2020","unstructured":"Cooper, J. T., Lloyd, A., Sanchez, J. J. G., S\u00f6rstadius, E., Briggs, A., & McFarlane, P. (2020). Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: A systematic literature review. Health and Quality of Life Outcomes., 18(1), 310. https:\/\/doi.org\/10.1186\/s12955-020-01559-x","journal-title":"Health and Quality of Life Outcomes."},{"issue":"8","key":"3966_CR22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10198-020-01195-8","volume":"21","author":"M Kennedy-Martin","year":"2020","unstructured":"Kennedy-Martin, M., Slaap, B., Herdman, M., van Reenen, M., Kennedy-Martin, T., Greiner, W., Busschbach, J., & Boye, K. S. (2020). Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines. The European Journal of Health Economics, 21(8), 1245\u20131257. https:\/\/doi.org\/10.1007\/s10198-020-01195-8","journal-title":"The European Journal of Health Economics"},{"issue":"Suppl 1","key":"3966_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40273-017-0544-y","volume":"35","author":"D Rowen","year":"2017","unstructured":"Rowen, D., Azzabi Zouraq, I., Chevrou-Severac, H., & van Hout, B. (2017). International regulations and recommendations for utility data for health technology assessment. PharmacoEconomics, 35(Suppl 1), 11\u201319. https:\/\/doi.org\/10.1007\/s40273-017-0544-y","journal-title":"PharmacoEconomics"},{"issue":"6","key":"3966_CR24","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s11136-021-02771-y","volume":"30","author":"A Ahmed","year":"2021","unstructured":"Ahmed, A., Saqlain, M., Bashir, N., Dujaili, J., Hashmi, F., Mazhar, F., Khan, A., Jabeen, M., Blebil, A., & Awaisu, A. (2021). Health-related quality of life and its predictors among adults living with HIV\/AIDS and receiving antiretroviral therapy in Pakistan. Quality of Life Research, 30(6), 1653\u20131664. https:\/\/doi.org\/10.1007\/s11136-021-02771-y","journal-title":"Quality of Life Research"},{"issue":"1","key":"3966_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s40271-021-00534-y","volume":"15","author":"SJ Anderson","year":"2022","unstructured":"Anderson, S. J., Murray, M., Cella, D., Grossberg, R., Hagins, D., Towner, W., Wang, M., Clark, A., Pierce, A., Llamoso, C., Ackerman, P., & Lataillade, M. (2022). Patient-reported outcomes in the phase III BRIGHTE trial of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals. The Patient: Patient-Centered Outcomes Research., 15(1), 131\u2013143. https:\/\/doi.org\/10.1007\/s40271-021-00534-y","journal-title":"The Patient: Patient-Centered Outcomes Research."},{"issue":"5","key":"3966_CR26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/QAI.0b013e3181a4f00d","volume":"51","author":"Anis AH, Nosyk B, Sun H, Guh DP, Bansback N, Li X, Barnett PG, Joyce V, Swanson KM, Kyriakides TC, Holodniy M, Cameron DW, Brown ST, Team O","year":"2009","unstructured":"Anis AH, Nosyk B, Sun H, Guh DP, Bansback N, Li X, Barnett PG, Joyce V, Swanson KM, Kyriakides TC, Holodniy M, Cameron DW, Brown ST, Team O. (2009). Quality of life of patients with advanced HIV\/AIDS: Measuring the impact of both AIDS-defining events and non-AIDS serious adverse events. Journal of Acquired Immune Deficiency Syndromes: JAIDS., 51(5), 631\u2013639. https:\/\/doi.org\/10.1097\/QAI.0b013e3181a4f00d","journal-title":"Journal of Acquired Immune Deficiency Syndromes: JAIDS."},{"key":"3966_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vhri.2020.09.002","volume":"25","author":"C Anosike","year":"2021","unstructured":"Anosike, C., Anene-Okeke, C. G., & Akunne, M. O. (2021). Assessment of health-related quality of life among patients infected With HIV receiving care in a Nigerian Tertiary Hospital. Value in Health Regional Issues., 25, 1\u20136. https:\/\/doi.org\/10.1016\/j.vhri.2020.09.002","journal-title":"Value in Health Regional Issues."},{"issue":"12","key":"3966_CR28","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/hec.1351","volume":"17","author":"N Bansback","year":"2008","unstructured":"Bansback, N., Sun, H., Guh, D. P., Li, X., Nosyk, B., Griffin, S., Barnett, P. G., & Anis, A. H. (2008). Impact of the recall period on measuring health utilities for acute events. Health Economics, 17(12), 1413\u20131419. https:\/\/doi.org\/10.1002\/hec.1351","journal-title":"Health Economics"},{"issue":"1","key":"3966_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12955-021-01670-7","volume":"19","author":"YB Belay","year":"2021","unstructured":"Belay, Y. B., Ali, E. E., Sander, B., & Gebretekle, G. B. (2021). Health-related quality of life of patients with HIV\/AIDS at a tertiary care teaching hospital in Ethiopia. Health & Quality of Life Outcomes., 19(1), 24. https:\/\/doi.org\/10.1186\/s12955-021-01670-7","journal-title":"Health & Quality of Life Outcomes."},{"issue":"4","key":"3966_CR30","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s11136-018-2044-8","volume":"28","author":"R Castro","year":"2019","unstructured":"Castro, R., De Boni, R. B., Luz, P. M., Velasque, L., Lopes, L. V., Medina-Lara, A., Cardoso, S. W., De Oliveira, M. S., Friedman, R. K., Grinsztejn, B., & Veloso, V. G. (2019). Health-related quality of life assessment among people living with HIV in Rio de Janeiro, Brazil: A cross-sectional study. Quality of Life Research, 28(4), 1035\u20131045. https:\/\/doi.org\/10.1007\/s11136-018-2044-8","journal-title":"Quality of Life Research"},{"key":"3966_CR31","unstructured":"ClinicalTrials.gov. [NCT00255099] TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114\/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options 2005. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00255099."},{"key":"3966_CR32","unstructured":"ClinicalTrials.gov. [NCT02831764] An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir\/Emtricitabine in Treatment na\u00efve HIV Infected Subjects (GEMINI-2) 2016. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02831764."},{"key":"3966_CR33","unstructured":"ClinicalTrials.gov. [NCT02831673] An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir\/Emtricitabine in Treatment na\u00efve HIV Infected Subjects (GEMINI-1) 2016. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02831673"},{"issue":"3","key":"3966_CR34","doi-asserted-by":"publisher","first-page":"E47","DOI":"10.1086\/318492","volume":"32","author":"T Delate","year":"2001","unstructured":"Delate, T., & Coons, S. J. (2001). The use of 2 health-related quality-of-life measures in a sample of persons infected with human immunodeficiency virus. Clinical Infectious Diseases, 32(3), E47-52. https:\/\/doi.org\/10.1086\/318492","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"3966_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/17290376.2013.870066","volume":"10","author":"J Gow","year":"2013","unstructured":"Gow, J., George, G., & Govender, K. (2013). A comparison of quality of life between HIV positive and negative diamond miners in South Africa. SAHARA J: Journal of Social Aspects of HIV\/AIDS Research Alliance., 10(2), 89\u201395. https:\/\/doi.org\/10.1080\/17290376.2013.870066","journal-title":"SAHARA J: Journal of Social Aspects of HIV\/AIDS Research Alliance."},{"issue":"1","key":"3966_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11136-005-8485-x","volume":"15","author":"S Honiden","year":"2006","unstructured":"Honiden, S., Sundaram, V., Nease, R. F., Holodniy, M., Lazzeroni, L. C., Zolopa, A., & Owens, D. K. (2006). The effect of diagnosis with HIV infection on health-related quality of Life. Quality of Life Research, 15(1), 69\u201382. https:\/\/doi.org\/10.1007\/s11136-005-8485-x","journal-title":"Quality of Life Research"},{"issue":"6","key":"3966_CR37","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s11136-007-9206-4","volume":"16","author":"IC Huang","year":"2007","unstructured":"Huang, I. C., Willke, R. J., Atkinson, M. J., Lenderking, W. R., Frangakis, C., & Wu, A. W. (2007). US and UK versions of the EQ-5D preference weights: Does choice of preference weights make a difference? Quality of Life Research, 16(6), 1065\u20131072. https:\/\/doi.org\/10.1007\/s11136-007-9206-4","journal-title":"Quality of Life Research"},{"issue":"4","key":"3966_CR38","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1177\/0272989X12453499","volume":"33","author":"Isogai PK, Rueda S, Rachlis AR, Rourke SB, Mittmann N, Team OCS","year":"2013","unstructured":"Isogai PK, Rueda S, Rachlis AR, Rourke SB, Mittmann N, Team OCS. (2013). Prediction of health preference values from CD4 counts in individuals with HIV. Medical Decision Making, 33(4), 558\u2013566. https:\/\/doi.org\/10.1177\/0272989X12453499","journal-title":"Medical Decision Making"},{"issue":"1","key":"3966_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/QAI.0b013e31818ce6f3","volume":"50","author":"VR Joyce","year":"2009","unstructured":"Joyce, V. R., Barnett, P. G., Bayoumi, A. M., Griffin, S. C., Kyriakides, T. C., Yu, W., Sundaram, V., Holodniy, M., Brown, S. T., Cameron, W., Youle, M., Sculpher, M., Anis, A. H., & Owens, D. K. (2009). Health-related quality of life in a randomized trial of antiretroviral therapy for advanced HIV disease. Journal of Acquired Immune Deficiency Syndromes: JAIDS., 50(1), 27\u201336. https:\/\/doi.org\/10.1097\/QAI.0b013e31818ce6f3","journal-title":"Journal of Acquired Immune Deficiency Syndromes: JAIDS."},{"issue":"1","key":"3966_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/0272989X10397615","volume":"32","author":"VR Joyce","year":"2012","unstructured":"Joyce, V. R., Barnett, P. G., Chow, A., Bayoumi, A. M., Griffin, S. C., Sun, H., Holodniy, M., Brown, S. T., Kyriakides, T. C., Cameron, D. W., Youle, M., Sculpher, M., Anis, A. H., & Owens, D. K. (2012). Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: A randomized, controlled trial. Medical Decision Making, 32(1), 70\u201382. https:\/\/doi.org\/10.1177\/0272989X10397615","journal-title":"Medical Decision Making"},{"issue":"Suppl 2","key":"3966_CR41","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1186\/s12879-021-06567-w","volume":"21","author":"M Kall","year":"2021","unstructured":"Kall, M., Fresan, U., Guy, D., Brown, G., Burgui, C., Castilla, J., Grecu, V. I., Dumitrescu, F., Delpech, V., & Lazarus, J. V. (2021). Quality of life in people living with HIV in Romania and Spain. BMC Infectious Diseases, 21(Suppl 2), 898. https:\/\/doi.org\/10.1186\/s12879-021-06567-w","journal-title":"BMC Infectious Diseases"},{"key":"3966_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.vhri.2016.05.001","volume":"11","author":"M Keaei","year":"2016","unstructured":"Keaei, M., Kuhlmann, J., Conde, R., Evers, S. M., Gonzalez, J., Govers, M., & Hiligsmann, M. (2016). Health-related quality of life of patients with HIV\/AIDS in Bogota. Colombia. Value in Health Regional Issues., 11, 68\u201372. https:\/\/doi.org\/10.1016\/j.vhri.2016.05.001","journal-title":"Colombia. Value in Health Regional Issues."},{"issue":"3","key":"3966_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/s0002-9343(02)01156-7","volume":"113","author":"LA Lenert","year":"2002","unstructured":"Lenert, L. A., Feddersen, M., Sturley, A., & Lee, D. (2002). Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infection. American Journal of Medicine, 113(3), 229\u2013232. https:\/\/doi.org\/10.1016\/s0002-9343(02)01156-7","journal-title":"American Journal of Medicine"},{"key":"3966_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1472-6963-9-55","volume":"9","author":"J Lopez-Bastida","year":"2009","unstructured":"Lopez-Bastida, J., Oliva-Moreno, J., Perestelo-Perez, L., & Serrano-Aguilar, P. (2009). The economic costs and health-related quality of life of people with HIV\/AIDS in the Canary Islands. Spain. BMC Health Serv Res., 9, 55. https:\/\/doi.org\/10.1186\/1472-6963-9-55","journal-title":"Spain. BMC Health Serv Res."},{"key":"3966_CR45","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2458-7-244","volume":"7","author":"GM Louwagie","year":"2007","unstructured":"Louwagie, G. M., Bachmann, M. O., Meyer, K., Booysen Fle, R., Fairall, L. R., & Heunis, C. (2007). Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: A cross-sectional analytical study. BMC Public Health, 7, 244. https:\/\/doi.org\/10.1186\/1471-2458-7-244","journal-title":"BMC Public Health"},{"issue":"7","key":"3966_CR46","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1080\/09540121.2016.1173639","volume":"28","author":"N Mafirakureva","year":"2016","unstructured":"Mafirakureva, N., Dzingirai, B., Postma, M. J., van Hulst, M., & Khoza, S. (2016). Health-related quality of life in HIV\/AIDS patients on antiretroviral therapy at a tertiary care facility in Zimbabwe. AIDS Care, 28(7), 904\u2013912. https:\/\/doi.org\/10.1080\/09540121.2016.1173639","journal-title":"AIDS Care"},{"issue":"3","key":"3966_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0192991","volume":"13","author":"H Maheswaran","year":"2018","unstructured":"Maheswaran, H., Petrou, S., Cohen, D., MacPherson, P., Kumwenda, F., Lalloo, D. G., Corbett, E. L., & Clarke, A. (2018). Economic costs and health-related quality of life outcomes of hospitalised patients with high HIV prevalence: A prospective hospital cohort study in Malawi. PLoS ONE, 13(3), e0192991. https:\/\/doi.org\/10.1371\/journal.pone.0192991","journal-title":"PLoS ONE"},{"issue":"3","key":"3966_CR48","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/QAI.0000000000001373","volume":"75","author":"H Maheswaran","year":"2017","unstructured":"Maheswaran, H., Petrou, S., MacPherson, P., Kumwenda, F., Lalloo, D. G., Corbett, E. L., & Clarke, A. (2017). Economic costs and health-related quality of life outcomes of HIV treatment after self- and facility-based HIV testing in a cluster randomized trial. Journal of Acquired Immune Deficiency Syndromes: JAIDS., 75(3), 280\u2013289. https:\/\/doi.org\/10.1097\/QAI.0000000000001373","journal-title":"Journal of Acquired Immune Deficiency Syndromes: JAIDS."},{"issue":"1","key":"3966_CR49","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1016\/S2352-3018(14)70018-9","volume":"1","author":"Miners A, Phillips A, Kreif N, Rodger A, Speakman A, Fisher M, Anderson J, Collins S, Hart G, Sherr L, Lampe FC, Study A","year":"2014","unstructured":"Miners A, Phillips A, Kreif N, Rodger A, Speakman A, Fisher M, Anderson J, Collins S, Hart G, Sherr L, Lampe FC, Study A. (2014). Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: A cross-sectional comparison with the general population. The Lancet HIV., 1(1), e32-40. https:\/\/doi.org\/10.1016\/S2352-3018(14)70018-9","journal-title":"The Lancet HIV."},{"issue":"6","key":"3966_CR50","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1310\/48et-tt7g-35ra-d4c3","volume":"2","author":"AH Miners","year":"2001","unstructured":"Miners, A. H., Sabin, C. A., Mocroft, A., Youle, M., Fisher, M., & Johnson, M. (2001). Health-related quality of life in individuals infected with HIV in the era of HAART. HIV Clinical Trials, 2(6), 484\u2013492. https:\/\/doi.org\/10.1310\/48et-tt7g-35ra-d4c3","journal-title":"HIV Clinical Trials"},{"issue":"Suppl 5","key":"3966_CR51","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1111\/j.1525-1497.2006.00644.x","volume":"21","author":"JM Mrus","year":"2006","unstructured":"Mrus, J. M., Leonard, A. C., Yi, M. S., Sherman, S. N., Fultz, S. L., Justice, A. C., & Tsevat, J. (2006). Health-related quality of life in veterans and nonveterans with HIV\/AIDS. Journal of General Internal Medicine, 21(Suppl 5), S39-47. https:\/\/doi.org\/10.1111\/j.1525-1497.2006.00644.x","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"3966_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12905-022-01646-9","volume":"22","author":"J Mwangi","year":"2022","unstructured":"Mwangi, J., Ternent, L., Ujiji, P. O. A., Were, E., & Ekstrom, A. M. (2022). Health related quality of life among pregnant women living with HIV in Kenya, results from comparing a patient generated index and the Euroqol 5 dimension 3 level. BMC Women\u2019s Health, 22(1), 66. https:\/\/doi.org\/10.1186\/s12905-022-01646-9","journal-title":"BMC Women\u2019s Health"},{"issue":"7","key":"3966_CR53","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s11136-009-9504-0","volume":"18","author":"B Nosyk","year":"2009","unstructured":"Nosyk, B., Sun, H., Bansback, N., Guh, D. P., Li, X., Barnett, P., Bayoumi, A., Griffin, S., Joyce, V., Holodniy, M., Owens, D. K., & Anis, A. H. (2009). The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV\/AIDS. Quality of Life Research, 18(7), 815\u2013824. https:\/\/doi.org\/10.1007\/s11136-009-9504-0","journal-title":"Quality of Life Research"},{"key":"3966_CR54","doi-asserted-by":"publisher","first-page":"174550652110687","DOI":"10.1177\/17455065211068722","volume":"18","author":"H Okhai","year":"2022","unstructured":"Okhai, H., Dragomir, L., Pool, E. R., Sabin, C. A., Miners, A., Sherr, L., Haag, K., Dhairyawan, R., Vora, N., Sultan, B., Gilson, R., Burns, F., Gilleece, Y., Jones, R., Post, F., Ross, J., Ustianowski, A., & Tariq, S. (2022). Association between health-related quality of life and menopausal status and symptoms in women living with HIV aged 45\u201360 years in England: An analysis of the PRIME study. Women\u2019s Health, 18, 17455065211068722. https:\/\/doi.org\/10.1177\/17455065211068722","journal-title":"Women\u2019s Health"},{"issue":"15","key":"3966_CR55","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.2165\/00019053-200321150-00005","volume":"21","author":"J Oliva","year":"2003","unstructured":"Oliva, J., Roa, C., & del Llano, J. (2003). Indirect costs in ambulatory patients with HIV\/AIDS in Spain: A pilot study. PharmacoEconomics, 21(15), 1113\u20131121. https:\/\/doi.org\/10.2165\/00019053-200321150-00005","journal-title":"PharmacoEconomics"},{"issue":"1","key":"3966_CR56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12955-017-0708-7","volume":"15","author":"AR Patel","year":"2017","unstructured":"Patel, A. R., Lester, R. T., Marra, C. A., van der Kop, M. L., Ritvo, P., Engel, L., Karanja, S., & Lynd, L. D. (2017). The validity of the SF-12 and SF-6D instruments in people living with HIV\/AIDS in Kenya. Health & Quality of Life Outcomes., 15(1), 143. https:\/\/doi.org\/10.1186\/s12955-017-0708-7","journal-title":"Health & Quality of Life Outcomes."},{"key":"3966_CR57","doi-asserted-by":"publisher","unstructured":"Podzamczer D, Rozas N, Domingo P, Miralles C, den Eynde EV, Romero A, Deig E, Knobel H, Pasquau J, Antela A, Clotet B, Geijo P, de Castro ER, Casado MA, Munoz A, Casado A, For The Pro-Str Study G. Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA R, Because of a Previous Intolerance to cART. PRO-STR Study. Current HIV Research. 2018;16(6):425\u201335 https:\/\/doi.org\/10.2174\/1570162X17666190212163518.","DOI":"10.2174\/1570162X17666190212163518"},{"key":"3966_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100177","volume":"8","author":"S Popping","year":"2021","unstructured":"Popping, S., Kall, M., Nichols, B. E., Stempher, E., Versteegh, L., van de Vijver, D., van Sighem, A., Versteegh, M., Boucher, C., Delpech, V., & Verbon, A. (2021). Quality of life among people living with HIV in England and the Netherlands: A population-based study. The Lancet Regional Health Europe., 8, 100177. https:\/\/doi.org\/10.1016\/j.lanepe.2021.100177","journal-title":"The Lancet Regional Health Europe."},{"key":"3966_CR59","doi-asserted-by":"publisher","DOI":"10.1080\/13607863.2022.2150143","author":"LT Quach","year":"2022","unstructured":"Quach, L. T., Ritchie, C. S., Tsai, A. C., Reynolds, Z., Paul, R., Seeley, J., Tong, Y., Hoeppner, S., Okello, S., Nakasujja, N., Olivieri-Mui, B., Saylor, D., Greene, M., Asiimwe, S., & Siedner, M. J. (2022). The benefits of care: treated HIV infection and health-related quality of life among older-aged people in Uganda. Aging & Mental Health. https:\/\/doi.org\/10.1080\/13607863.2022.2150143","journal-title":"Aging & Mental Health"},{"issue":"2","key":"3966_CR60","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1524-4733.2008.00440.x","volume":"12","author":"P Sakthong","year":"2009","unstructured":"Sakthong, P., Schommer, J. C., Gross, C. R., Prasithsirikul, W., & Sakulbumrungsil, R. (2009). Health utilities in patients with HIV\/AIDS in Thailand. Value Health., 12(2), 377\u2013384. https:\/\/doi.org\/10.1111\/j.1524-4733.2008.00440.x","journal-title":"Value Health."},{"key":"3966_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.vhri.2014.02.009","volume":"3","author":"P Sakthong","year":"2014","unstructured":"Sakthong, P., Winit-Watjana, W., & Choopan, K. (2014). Usefulness of patient-generated index for HIV to measure individual quality of life: a study from Thailand. Value in Health Regional Issues., 3, 101\u2013107. https:\/\/doi.org\/10.1016\/j.vhri.2014.02.009","journal-title":"Value in Health Regional Issues."},{"issue":"1","key":"3966_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2989\/16085906.2021.2013907","volume":"21","author":"T Shimels","year":"2022","unstructured":"Shimels, T., Bogale, G., Asrat Kassu, R., & Gedif, T. (2022). Quality of life and its predictors among clients visiting antiretroviral therapy clinics in Addis Ababa. Ethiopia. Afr J AIDS Res., 21(1), 15\u201322. https:\/\/doi.org\/10.2989\/16085906.2021.2013907","journal-title":"Ethiopia. Afr J AIDS Res."},{"issue":"4","key":"3966_CR63","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s11136-004-3211-7","volume":"14","author":"K Stavem","year":"2005","unstructured":"Stavem, K., Froland, S. S., & Hellum, K. B. (2005). Comparison of preference-based utilities of the 15D, EQ-5D and SF-6D in patients with HIV\/AIDS. Quality of Life Research, 14(4), 971\u2013980. https:\/\/doi.org\/10.1007\/s11136-004-3211-7","journal-title":"Quality of Life Research"},{"issue":"11","key":"3966_CR64","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1177\/0956462413486454","volume":"24","author":"S Surah","year":"2013","unstructured":"Surah, S., Adams, R., Townsend, L., Reynolds, I., Kinahan, J. C., Keating, S., Mulcahy, F., Keenan, E., Barry, M., & Lyons, F. (2013). Health-related quality of life of HIV-infected intravenous drug users. International Journal of STD and AIDS, 24(11), 867\u2013874. https:\/\/doi.org\/10.1177\/0956462413486454","journal-title":"International Journal of STD and AIDS"},{"issue":"9","key":"3966_CR65","doi-asserted-by":"publisher","first-page":"36","DOI":"10.22159\/ijpps.2020v12i9.38628","volume":"12","author":"K Suryana","year":"2020","unstructured":"Suryana, K., Suharsono, H., & Joenputri, N. (2020). Factors associated with qualilty of life among people living with HIV\/AIDS on highly active antiretroviral therapy: a cross-sectional study. International Journal of Pharmacy and Pharmaceutical Sciences., 12(9), 36\u201340. https:\/\/doi.org\/10.22159\/ijpps.2020v12i9.38628","journal-title":"International Journal of Pharmacy and Pharmaceutical Sciences."},{"issue":"11","key":"3966_CR66","doi-asserted-by":"publisher","first-page":"e1133","DOI":"10.1016\/S2214-109X(17)30367-4","volume":"5","author":"Thomas R, Burger R, Harper A, Kanema S, Mwenge L, Vanqa N, Bell-Mandla N, Smith PC, Floyd S, Bock P, Ayles H, Beyers N, Donnell D, Fidler S, Hayes R, Hauck K, Team HS","year":"2017","unstructured":"Thomas R, Burger R, Harper A, Kanema S, Mwenge L, Vanqa N, Bell-Mandla N, Smith PC, Floyd S, Bock P, Ayles H, Beyers N, Donnell D, Fidler S, Hayes R, Hauck K, Team HS. (2017). Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: A cross-sectional baseline survey of the HPTN 071 (PopART) trial. The Lancet Global Health., 5(11), e1133\u2013e1141. https:\/\/doi.org\/10.1016\/S2214-109X(17)30367-4","journal-title":"The Lancet Global Health."},{"issue":"12","key":"3966_CR67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/ijerph15122888","volume":"15","author":"BX Tran","year":"2018","unstructured":"Tran, B. X., Dang, A. K., Truong, N. T., Ha, G. H., Nguyen, H. L. T., Do, H. N., Nguyen, T. Q., Latkin, C. A., Ho, C. S. H., & Ho, R. C. M. (2018). Depression and quality of life among patients living with HIV\/AIDS in the era of universal treatment access in Vietnam. International Journal of Environmental Research & Public Health [Electronic Resource]., 15(12), 17. https:\/\/doi.org\/10.3390\/ijerph15122888","journal-title":"International Journal of Environmental Research & Public Health [Electronic Resource]."},{"issue":"10","key":"3966_CR68","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1080\/09540121.2011.555749","volume":"23","author":"BX Tran","year":"2011","unstructured":"Tran, B. X., Ohinmaa, A., Nguyen, L. T., Nguyen, T. A., & Nguyen, T. H. (2011). Determinants of health-related quality of life in adults living with HIV in Vietnam. AIDS Care, 23(10), 1236\u20131245. https:\/\/doi.org\/10.1080\/09540121.2011.555749","journal-title":"AIDS Care"},{"issue":"2","key":"3966_CR69","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s11482-021-09939-1","volume":"17","author":"M Treskova","year":"2022","unstructured":"Treskova, M., Scholz, S., Kuhlmann, A., Mahlich, J., & Stoll, M. (2022). Estimation of health-state utility values and factors driving health-related quality of life in people living with HIV and AIDS and receiving cART in Germany: baseline analysis of a cohort study. Applied Research in Quality of Life., 17(2), 851\u2013869. https:\/\/doi.org\/10.1007\/s11482-021-09939-1","journal-title":"Applied Research in Quality of Life."},{"issue":"3","key":"3966_CR70","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/14737167.2017.1246185","volume":"17","author":"MJ Van Duin","year":"2017","unstructured":"Van Duin, M. J., Conde, R., Wijnen, B., Evers, S. M., Gonzalez-Rodriguez, J. L., Govers, M. J., & Hiligsmann, M. (2017). The impact of comorbidities on costs, utilities and health-related quality of life among HIV patients in a clinical setting in Bogota. Expert Review of Pharmacoeconomics & Outcomes Research, 17(3), 303\u2013310. https:\/\/doi.org\/10.1080\/14737167.2017.1246185","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"issue":"4","key":"3966_CR71","doi-asserted-by":"publisher","first-page":"830","DOI":"10.18549\/PharmPract.2016.04.830","volume":"14","author":"T Velvanathan","year":"2016","unstructured":"Velvanathan, T., Islahudin, F., Sim, B. L., & Taha, N. A. (2016). Simplification of HAART therapy on ambulatory HIV patients in Malaysia: a randomized controlled trial. Pharmacy Practice (Granada)., 14(4), 830. https:\/\/doi.org\/10.18549\/PharmPract.2016.04.830","journal-title":"Pharmacy Practice (Granada)."},{"key":"3966_CR72","doi-asserted-by":"publisher","unstructured":"Wang L, Dowdy DW, Comins CA, Young K, McIngana M, Mulumba N, Mhlophe H, Chen C, Hausler H, Schwartz SR, Baral S, Mishra S, Siyaphambili Study t. Health-related quality of life of female sex workers living with HIV in South Africa: a cross-sectional study. J Int AIDS Soc. 2022;25(2):e25884 https:\/\/doi.org\/10.1002\/jia2.25884.","DOI":"10.1002\/jia2.25884"},{"issue":"1","key":"3966_CR73","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40249-021-00890-9","volume":"10","author":"X Wang","year":"2021","unstructured":"Wang, X., Luo, H., Yao, E., Tang, R., Dong, W., Liu, F., Liang, J., Li, H., Xiao, M., Zhang, Z., Niu, J., Song, L., Fu, L., Li, X., Qian, S., Guo, Q., & Song, Z. (2021). The role of personality, social economic and prevention strategy effects on health-related quality of life among people living with HIV\/AIDS. Infectious Diseases of Poverty., 10(1), 104. https:\/\/doi.org\/10.1186\/s40249-021-00890-9","journal-title":"Infectious Diseases of Poverty."},{"issue":"45","key":"3966_CR74","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000031666","volume":"101","author":"X Wang","year":"2022","unstructured":"Wang, X., Luo, H., Yao, E., Tang, R., Dong, W., Liu, F., Liang, J., Xiao, M., Zhang, Z., Niu, J., Song, L., Fu, L., Li, X., Qian, S., Guo, Q., & Song, Z. (2022). Health utility measurement for people living with HIV\/AIDS under combined antiretroviral therapy: A comparison of EQ-5D-5L and SF-6D. Medicine, 101(45), e31666. https:\/\/doi.org\/10.1097\/md.0000000000031666","journal-title":"Medicine"},{"key":"3966_CR75","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s10198-022-01465-7","volume":"10","author":"G Weng","year":"2022","unstructured":"Weng, G., Hong, Y., Luo, N., Mukuria, C., Jiang, J., Yang, Z., & Li, S. (2022). Comparing EQ-5D-3L and EQ-5D-5L in measuring the HRQoL burden of 4 health conditions in China. European Journal of Health Economics., 10, 10. https:\/\/doi.org\/10.1007\/s10198-022-01465-7","journal-title":"European Journal of Health Economics."},{"issue":"10167","key":"3966_CR76","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/s0140-6736(18)32462-0","volume":"393","author":"P Cahn","year":"2019","unstructured":"Cahn, P., Madero, J. S., Arribas, J. R., Antinori, A., Ortiz, R., Clarke, A. E., Hung, C. C., Rockstroh, J. K., Girard, P. M., Sievers, J., Man, C., Currie, A., Underwood, M., Tenorio, A. R., Pappa, K., Wynne, B., Fettiplace, A., Gartland, M., Aboud, M., & Smith, K. (2019). Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): Week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials. Lancet, 393(10167), 143\u2013155. https:\/\/doi.org\/10.1016\/s0140-6736(18)32462-0","journal-title":"Lancet"},{"issue":"3","key":"3966_CR77","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/qai.0000000000002275","volume":"83","author":"P Cahn","year":"2020","unstructured":"Cahn, P., Madero, J. S., Arribas, J. R., Antinori, A., Ortiz, R., Clarke, A. E., Hung, C. C., Rockstroh, J. K., Girard, P. M., Sievers, J., Man, C. Y., Urbaityte, R., Brandon, D. J., Underwood, M., Tenorio, A. R., Pappa, K. A., Wynne, B., Gartland, M., Aboud, M., \u2026 Smith, K. Y. (2020). Durable efficacy of dolutegravir plus lamivudine in antiretroviral treatment-naive adults with HIV-1 infection: 96-week results from the GEMINI-1 and GEMINI-2 randomized clinical trials. Journal of Acquired Immune Deficiency Syndromes, 83(3), 310\u2013318. https:\/\/doi.org\/10.1097\/qai.0000000000002275","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"3966_CR78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/RMHP.S8997","volume":"4","author":"M Williams","year":"2011","unstructured":"Williams, M. (2011). Confidentiality of the medical records of HIV-positive patients in the United Kingdom\u2014a medicolegal and ethical perspective. Risk Management Healthc Policy., 4, 15\u201326. https:\/\/doi.org\/10.2147\/RMHP.S8997","journal-title":"Risk Management Healthc Policy."},{"issue":"1","key":"3966_CR79","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1080\/13696998.2022.2066441","volume":"25","author":"N Poudel","year":"2022","unstructured":"Poudel, N., Fahim, S. M., Qian, J., Garza, K., Chaiyakunapruk, N., & Ngorsuraches, S. (2022). Methodological similarities and variations among EQ-5D-5L value set studies: a systematic review. Journal of Medical Economics, 25(1), 571\u2013582.","journal-title":"Journal of Medical Economics"},{"issue":"3","key":"3966_CR80","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jval.2016.10.002","volume":"20","author":"AN Lamu","year":"2017","unstructured":"Lamu, A. N., Gamst-Klaussen, T., & Olsen, J. A. (2017). Preference weighting of health state values: what difference does it make, and why? Value Health., 20(3), 451\u2013457. https:\/\/doi.org\/10.1016\/j.jval.2016.10.002","journal-title":"Value Health."},{"issue":"1","key":"3966_CR81","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13104-019-4067-9","volume":"12","author":"C Gerlinger","year":"2019","unstructured":"Gerlinger, C., Bamber, L., Leverkus, F., Schwenke, C., Haberland, C., Schmidt, G., & Endrikat, J. (2019). Comparing the EQ-5D-5L utility index based on value sets of different countries: Impact on the interpretation of clinical study results. BMC Research Notes, 12(1), 18. https:\/\/doi.org\/10.1186\/s13104-019-4067-9","journal-title":"BMC Research Notes"},{"issue":"6","key":"3966_CR82","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/QAD.0000000000003514","volume":"37","author":"CD Johnston","year":"2023","unstructured":"Johnston, C. D., O\u2019Brien, R., & Cote, H. C. F. (2023). Inclusion of women in HIV research and clinical trials. AIDS, 37(6), 995\u2013997. https:\/\/doi.org\/10.1097\/QAD.0000000000003514","journal-title":"AIDS"},{"issue":"12","key":"3966_CR83","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1080\/17512433.2019.1698946","volume":"12","author":"MC Masters","year":"2019","unstructured":"Masters, M. C., Krueger, K. M., Williams, J. L., Morrison, L., & Cohn, S. E. (2019). Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States. Expert Review of Clinical Pharmacology, 12(12), 1129\u20131143.","journal-title":"Expert Review of Clinical Pharmacology"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-025-03966-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-025-03966-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-025-03966-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:04:19Z","timestamp":1757948659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-025-03966-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":83,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3966"],"URL":"https:\/\/doi.org\/10.1007\/s11136-025-03966-3","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"24 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ian Jacob and Christina Donatti are employees of ViiV Healthcare and hold financial equities in GSK. Edith Poku, Matthew Franklin, Emma Simpson, and Louise Falzon have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"As this was a systematic literature review no ethics approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participation"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}